Companies / Mira Pharmaceuticals, Inc.

Mira Pharmaceuticals, Inc.

Nasdaq: MIRACIK 1904286MIAMI, FL

Financials

Revenue
Net income$-10.44M
Total debt
Cash$3.61M
Diluted EPS$-1.35
Shares outstanding42.0M

Ownership

42.0M shares outstanding · as of Aug 10, 2026
8.5%Insiders
Ownership
Insiders8.55%3,592,666
Institutions5.61%2,356,678
Public float85.84%36,072,743

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Aminov ErezCEOCEO and Chairman · Director
8.55%3,592,666

Institutional holders 25

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Oct 16, 2025Aminov Erez
CEO
SellCommon Stock$1.29M-614K
-14.59%
3,592,666
8.55% of shares
medium
Oct 16, 2025Aminov Erez
CEO
ExerciseCommon Stock$318.4K+379K
+9.90%
4,206,259
10.01% of shares
low
Oct 16, 2025Aminov Erez
CEO
ExerciseCommon Stock$272.1K+235K
+6.53%
3,827,259
9.11% of shares
low
Mar 26, 2025Aminov Erez
CEO
GrantCommon Stock$90.6K+63K
+1.77%
3,592,666
8.55% of shares
low
Mar 26, 2025Aminov Erez
CEO
GrantCommon Stock$90.6K+63K
+1.80%
3,530,166
8.40% of shares
low
Dec 17, 2025Aminov Erez
CEO
GrantStock Options (right to buy)+3.2M
3,155,170
7.51% of shares
low
Oct 16, 2025Aminov Erez
CEO
ExerciseStock Options (right to buy)+379K
379,000
0.90% of shares
low
Oct 16, 2025Aminov Erez
CEO
ExerciseStock Options (right to buy)+235K
234,595
0.56% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MIRACommon StockEquity60458C104BBG01H8XP5F5